For Scientists

研究開発

Home>For Scientists

論文

2016年

Response by Steinberg et al to Letter Regarding Article, "Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2A Study".
Steinberg GK, Kondziolka D, Bates D; SB623 Stroke Phase 1/2A Study Group.
Stroke. 2016 Dec;47(12):e269. Epub 2016 Nov 15. doi: 10.1161/STROKEAHA.116.015209

αSMA Expression in Large Colonies of Colony-Forming Units-Fibroblast as an Early Predictor of Bone Marrow MSC Expandability.
Aizman I, Holland WS, Yang C, Bates D.
Cell Med. 2016 Oct 6;8(3):79-85. doi: 10.3727/215517916X693357. eCollection 2016 Dec 3.

Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.
Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, Kim AS, Johnson JN, Bates D, King B, Case C, McGrogan M, Yankee EW, Schwartz NE.
Stroke. 2016 Jul;47(7):1817-24. doi: 10.1161/STROKEAHA.116.012995. Epub 2016 Jun 2.

2015年

Cell Injury-Induced Release of Fibroblast Growth Factor 2: Relevance to Intracerebral Mesenchymal Stromal Cell Transplantations.
Aizman I, Vinodkumar D, McGrogan M, Bates D.
Stem Cells Dev. 2015 Jul 15;24(14):1623-34. doi: 10.1089/scd.2015.0083. Epub 2015 May 20.

Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease.
Tate CC, Chou VP, Campos C, Moalem AS, Di Monte DA, McGrogan M, Case CC, Manning-Bog AB.
J Tissue Eng Regen Med. 2015 Oct 6. doi: 10.1002/term.2081. Epub ahead of print

2014年

Comparison of the neuropoietic activity of gene-modified versus parental mesenchymal stromal cells and the identification of soluble and extracellular matrix-related neuropoietic mediators.
Aizman I, Tirumalashetty BJ, McGrogan M, Case CC.
Stem Cell Res Ther. 2014 Feb 26;5(1):29. doi: 10.1186/scrt418.

Stem cell-paved biobridge facilitates neural repair in traumatic brain injury.
Tajiri N, Duncan K, Antoine A, Pabon M, Acosta SA, de la Pena I, Hernadez-Ontiveros DG, Shinozuka K, Ishikawa H, Kaneko Y, Yankee E, McGrogan M, Case C, Borlongan CV.
Front Syst Neurosci. 2014 Jun 24;8:116. doi: 10.3389/fnsys.2014.00116. eCollection 2014

2013年

Stem cell recruitment of newly formed host cells via a successful seduction? filling the gap between neurogenic niche and injured brain site
Tajiri N, Kaneko Y, Shinozuka K, Ishikawa H, Yankee E, McGrogan M, Case CC, Cesar V. Borlongan CV
PLoS ONE 2013 Sep 4;8(9): e74857. doi: 10.1371/journal.pone.0074857. eCollection 2013

Proteomic analysis of the extracellular matrix produced by mesenchymal stromal cells: implications for cell therapy mechanism
Harvey A, Yen TY, Aizman I, Tate C, Case C
PLoS ONE 2013 Nov 14;8(11): e79283. doi: 10.1371/journal.pone.0079283. eCollection 2013

Comparing the angiogenic potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells
Dao M, Tate CC, McGrogan M, Case CC.
J Transl Med. 2013 Mar 27;11:81. doi: 10.1186/1479-5876-11-81

Quantitative microplate assay for studying mesenchymal stromal cell-induced neuropoiesis
Aizman I, McGrogan M, Case CC.
Stem Cells Transl Med. 2013 Mar;2(3):223-32. doi: 10.5966/sctm.2012-0119. Epub 2013 Feb 19.

Immunosuppressive activity of adult marrow mesenchymal stromal cells on innate immune cells in the central nervous system
Dao MA, Nolta JA, and Case CC
Advances in Neuroimmune Biology 2013, 4:177-185. doi: 10.3233/NIB-130064

2012年

Mesenchymal Stromal Cells to Treat Brain Injury
Tate CC and Case CC
Chapter in "Neurological Disorders", InTech, 2012

Transplanted Mesenchymal Stem Cells Aid the Injured Brain through Trophic Support Mechanisms
Tate CC and Case CC
Chapter in "Stem Cells and Cancer Stem Cells, Vol 4", M.A. Hayat (Ed), 2012

2011年

Comparing the immunosuppressive potency of naive marrow stromal cells and Notch-transfected marrow stromal cells
Dao MA, Tate CC, Aizman I, McGrogan M, Case CC.
J Neuroinflammation. 2011 Oct 7;8:133. doi: 10.1186/1742-2094-8-133.

2010年

Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia
Tate CC, Fonck C, McGrogan M, Case CC.
Cell Transplant. 2010,19(8):973-84. doi: 10.3727/096368910X494885. Epub 2010 Mar 26.

Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease
Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC.
J Neurosci Res. 2010 Sep;88(12):2669-81. doi: 10.1002/jnr.22435.

2009年

Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth
Aizman I, Tate CC, McGrogan M, Case CC.
J Neurosci Res. 2009 Nov 1;87(14):3198-206. doi: 10.1002/jnr.22146.

Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals.
Yasuhara T, Matsukawa N, Hara K, Maki M, Ali MM, Yu SJ, Bae E, Yu G, Xu L, McGrogan M, Bankiewicz K, Case C, Borlongan CV.
Stem Cells Dev. 2009 Dec;18(10):1501-14. doi: 10.1089/scd.2009.0011.

Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors
Glavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan M, Dugich-Djordjevic M, Bohn MC.
Cell Transplant. 2009, 18(7):801-14. doi: 10.3727/096368909X470801. Epub 2009 Sep 28.

ページの先頭へ
閉じる